Further Kaplan–Meier survival analysis using databases indicated that while the OS of GC patients with high TP73-AS1 expression did not show significant statistical differences compared to those with low expression, there was a significant difference in disease-free survival (DFS) (Figure 3b). This evidence concerns the gene TP73 and gastric cancer.